Search hospitals > Maryland > Baltimore
Sinai Hospital of Baltimore
Claim this profileBaltimore, Maryland 21215
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Soft Tissue Sarcoma
Conducts research for Brain Tumor
Conducts research for Neuroblastoma
388 reported clinical trials
26 medical researchers
Summary
Sinai Hospital of Baltimore is a medical facility located in Baltimore, Maryland. This center is recognized for care of Cancer, Lung Cancer, Soft Tissue Sarcoma, Brain Tumor, Neuroblastoma and other specialties. Sinai Hospital of Baltimore is involved with conducting 388 clinical trials across 596 conditions. There are 26 research doctors associated with this hospital, such as Jason M. Fixler, Pallavi Kumar, MD, Qiwei W. Gai, and Maitri Kalra.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Jason M. FixlerSinai Hospital of Baltimore8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
55 reported clinical trials
106 drugs studied
Pallavi Kumar, MDSinai Hospital of Baltimore2 years of reported clinical research
Studies Uterine Cancer
Studies Ovarian Cancer
11 reported clinical trials
44 drugs studied
Qiwei W. GaiWilliam E Kahlert Regional Cancer Center/Sinai Hospital2 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
17 drugs studied
Maitri KalraSinai Hospital of Baltimore2 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
24 drugs studied
Clinical Trials running at Sinai Hospital of Baltimore
Lung Cancer
Breast Cancer
Pancreatic Cancer
Breast cancer
Uterine Cancer
Cancer
Melanoma
Testicular cancer
Osteoarthritis
Acute Lymphoblastic Leukemia
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sinai Hospital of Baltimore?
Sinai Hospital of Baltimore is a medical facility located in Baltimore, Maryland. This center is recognized for care of Cancer, Lung Cancer, Soft Tissue Sarcoma, Brain Tumor, Neuroblastoma and other specialties. Sinai Hospital of Baltimore is involved with conducting 388 clinical trials across 596 conditions. There are 26 research doctors associated with this hospital, such as Jason M. Fixler, Pallavi Kumar, MD, Qiwei W. Gai, and Maitri Kalra.
Where is Sinai Hospital of Baltimore located?
**Directions to Sinai Hospital of Baltimore:**
- Address: 2401 W Belvedere Ave, Baltimore, MD 21215.
- From I-83 South, take exit 10 for Northern Parkway.
- Head west on Northern Parkway, turn left onto West Belvedere Avenue, and the hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
**Sinai Hospital of Baltimore Contact Information**
**Financial Assistance:**
- **Phone:** 1-800-788-6995
- **Mail:** Attn: Customer Service, 5401 Old Court Rd., Randallstown, MD 21133
**Insurance:**
- **Phone:** 1-800-788-6995
- **Email:** LBHCustomerService@lifebridgehealth.org
These contacts are available for assistance with financial hardship, offering discounts for patients with an annual income up to 300% of the federal poverty level, and addressing insurance plan concerns.
What insurance does Sinai Hospital of Baltimore accept?
Sinai Hospital of Baltimore accepts numerous insurance plans, such as Advantra Freedom, Diamond Plan Medicaid, First Health, Health and Life, Indemnity, National, POS, and PPO-Health Assurance, among others. The hospital also participates in Medicare and Medical Assistance programs. For full coverage verification or if your plan is not listed, please contact Sinai Hospital or your insurance provider directly.
What awards or recognition has Sinai Hospital of Baltimore received?
Sinai Hospital of Baltimore is renowned for its contributions to medical innovation and patient care. It has earned prestigious recognitions, including a notable award that places it among the top five hospitals in Maryland and the Great Place to Work Certification for five consecutive years. The hospital also operates the Sinai Center for Thrombosis Research, focusing on translational research in thrombosis for patients undergoing interventional cardiovascular procedures.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.